These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 8146976)

  • 1. Sensitivity of the fibrinogen clotting time: an in vitro test of potential thrombogenicity.
    Feldman PA; McGrath S; Evans H
    Vox Sang; 1994; 66(1):1-7. PubMed ID: 8146976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of S-protein of complement with thrombin and antithrombin III during coagulation. Protection of thrombin by S-protein from antithrombin III inactivation.
    Podack ER; Dahlbäck B; Griffin JH
    J Biol Chem; 1986 Jun; 261(16):7387-92. PubMed ID: 3754869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of acetylthrombin on protein C activation and fibrinogen clotting.
    Nakagomi K; Ajisaka K; Yokota I
    Thromb Res; 1990 Aug; 59(4):713-22. PubMed ID: 1964250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thrombin generation is not increased in the blood of hemophilia B patients after the infusion of a purified factor IX concentrate.
    Mannucci PM; Bauer KA; Gringeri A; Barzegar S; Bottasso B; Simoni L; Rosenberg RD
    Blood; 1990 Dec; 76(12):2540-5. PubMed ID: 2265248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of heparin, hirudin, and a synthetic thrombin inhibitor on antithrombin III in thrombin-induced disseminated intravascular coagulation in rats.
    Hauptmann J; Brüggener E; Markwardt F
    Haemostasis; 1987; 17(6):321-8. PubMed ID: 3428717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. On the mechanism of coagulation inhibition on surfaces with end point immobilized heparin.
    Elgue G; Blombäck M; Olsson P; Riesenfeld J
    Thromb Haemost; 1993 Aug; 70(2):289-93. PubMed ID: 8236137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergistic effect of antithrombin III, activated protein C and heparin on the inhibition of the tissue thromboplastin-mediated coagulation.
    Hirahara K; Etoh Y; Matsuishi T; Suzuki N; Kurata M
    Chem Pharm Bull (Tokyo); 1989 Mar; 37(3):692-6. PubMed ID: 2752479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Different Heparin Contents in Prothrombin Complex Concentrates May Impair Blood Clotting in Outpatients With Ventricular Assist Devices Receiving Phenprocoumon.
    Felli A; Zeidler P; Jilma B; Opfermann P; Holaubek C; Zimpfer D; Wadowski PP; Steinlechner B
    J Cardiothorac Vasc Anesth; 2016 Jan; 30(1):96-101. PubMed ID: 26613641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Real-time measurement of free thrombin: evaluation of the usability of a new thrombin assay for coagulation monitoring during extracorporeal circulation.
    Krajewski S; Krauss S; Kurz J; Neumann B; Schlensak C; Wendel HP
    Thromb Res; 2014 Mar; 133(3):455-63. PubMed ID: 24359968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antithrombin III: a backward glance o'er travel'd roads.
    Seegers WH
    Adv Exp Med Biol; 1975; 52():195-215. PubMed ID: 47704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction of protamine sulfate with thrombin.
    Cobel-Geard RJ; Hassouna HI
    Am J Hematol; 1983 May; 14(3):227-33. PubMed ID: 6846326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of prothrombin as a major thrombogenic agent in prothrombin complex concentrates.
    Dusel CH; Grundmann C; Eich S; Seitz R; König H
    Blood Coagul Fibrinolysis; 2004 Jul; 15(5):405-11. PubMed ID: 15205589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemical modification of alpha-thrombin and in vitro characterization of its anticoagulant activity.
    Nakagomi K; Ajisaka K
    Biochem Int; 1990 Oct; 22(1):75-84. PubMed ID: 2177988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heparin sensitivity and resistance in the neonate: an explanation.
    Vieira A; Berry L; Ofosu F; Andrew M
    Thromb Res; 1991 Jul; 63(1):85-98. PubMed ID: 1658964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro studies on thrombin generation in citrated, r-hirudinized and heparinized whole blood.
    Kaiser B; Fareed J; Walenga JM; Hoppensteadt D; Markwardt F
    Thromb Res; 1991 Dec; 64(5):589-96. PubMed ID: 1808763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clot-bound thrombin is protected from inhibition by heparin-antithrombin III but is susceptible to inactivation by antithrombin III-independent inhibitors.
    Weitz JI; Hudoba M; Massel D; Maraganore J; Hirsh J
    J Clin Invest; 1990 Aug; 86(2):385-91. PubMed ID: 2384594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of dextran sulphates on thrombin activity.
    Suzuki K; Hashimoto S
    J Clin Pathol; 1979 May; 32(5):439-44. PubMed ID: 469001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Placental protein 5 (PP5) inhibits thrombin-induced coagulation of fibrinogen.
    Meisser A; Bischof P; Bohn H
    Arch Gynecol; 1985; 236(4):197-201. PubMed ID: 4026390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The anticoagulant effect of heparin + antithrombin III using purified fibrinogen as substrate.
    Andersen P; Godal HC
    Haemostasis; 1977; 6(6):329-38. PubMed ID: 611046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prothrombin fragment 1 + 2, thrombin-antithrombin III-complexes and fibrinopeptide A in spontaneously clotting whole blood in vitro. Effects of heparin addition and antithrombin III deficiency.
    Herren T; Straub PW; Haeberli A
    Thromb Haemost; 1994 Jan; 71(1):49-53. PubMed ID: 8165646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.